Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial.

Author(s): Chagas MH, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, dos Santos AC, Teixeira AL, Hallak JE, Crippa JA

Department of Neuroscience and Behavior, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil INCT Translational Medicine (CNPq), São Paulo, Brazil Barretos School of Health Sciences - Dr. Paulo Prata, Barretos, Brazil [email protected] [email protected]

Subject: Parkinson's Disease View the study

Abstract:

Parkinson's disease (PD) has a progressive course and is characterized by the degeneration of dopaminergic neurons. Although no neuroprotective treatments for PD have been found to date, the endocannabinoid system has emerged as a promising target.

Source: Journal of Psychopharmacology (Price: $40)
Share Tweet

More medical studies related to Parkinson's Disease:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

читайте здесь

learn more seotexts.com

узнать больше